logo
  • Downloads
  • Client Login
  • About Us
    • Why DesertSci?
    • Our History
    • Our Approach
    • Our Clients
    • Publications
    • Contact Us
  • Products
    • Proasis: Protein Structure Database
    • ViewContacts: Non-Covalent Interactions
    • Scorpion: Scoring
    • Viper: Automated Ligand Design
    • Machine Learning: Next Level Scoring
    • ProFusion: Collaboration
    • FELIX: Drug Repurposing
    • Spinifex: Chemical Similarity
    • BMOS: MOS for Large Datasets
  • Software Modules
    • Atom-Based Binding Site Clustering
    • Antibody Structure Based Drug Discovery
    • Antibody Complementarity Determining Regions
    • Antibody-Antigen Interactions
    • Residue Flexibility
    • WaterRank
    • WaterView
  • Modelling Support
  • Licensing
  • Latest News
Home > Our Products > Machine Learning: Next Level Scoring

  • Proasis: Protein Structure Database
  • ViewContacts: Non-Covalent Interactions
  • Scorpion: Scoring
  • Viper: Automated Ligand Design
  • FELIX: Drug Repurposing
  • ProFusion: Collaboration
  • Machine Learning: Next Level Scoring
  • Spinifex: Chemical Similarity
  • BMOS: MOS for Large Datasets
logo

Machine Learning: Next Level Scoring of Ligand Binding Affinity

Machine learning and AI dominate recent developments in computing.  DesertSci is uniquely placed to apply ML/AI in the field of scoring protein-ligand binding affinity.

With Scorpion, our empirical scoring function developed in collaboration with top experts in the field, we have unparalleled know-how in building ranking methods.

With Proasis, our protein-structure database system, we have extensive knowledge in working with large quantities of 3D protein-ligand coordinate data.

Together, with new AI technology, we will unlock the key factors driving tight ligand binding … ranking better, faster.  Our software will identify the top drug candidates, among a sea of others, and deliver them to your scientists all day, every day.

Better Ranking = Better Drug Candidates in Larger Quantities

Meaning  real savings, in both time and money, during the early stage drug discovery process.

We are creating a ranking scheme based purely on protein structure data rather than relying on experimental affinity data, because the latter is severely limited by the availability of high-quality data. Furthermore, our strategy focuses on creating a ranking scheme based on non-covalent interactions, network descriptors, and protein flexibility.

Our ML technologies are a work in progress but early results are extremely promising.  We are developing the technology at a fast pace and look forward to testing our methods extensively amongst the Desertsci user community.

Watch this space …

 

icon

News & Events

15 Oct 2025

The mmCIF revolution: future-proofing drug discovery pipelines

15 Oct 2025

Critical foundations: data management and security in modern scientific organisations

14 Oct 2025

33rd PSDI Conference Basel, Switzerland

30 Aug 2025

Discovering hidden outliers in PDB bulk releases with automated analysis

more articles
image

Looking for FREE Academic Software?

find out more
Logo
  • contact
  • desertsci
  • info@www.desertsci.com

    © 2011-2025 Desert Scientific Software

    • About Us
    • Our Products
    • Software Modules
    • Modelling Support
    • Licensing
    • News & Events
    Website by The Walk